Imunon (IMNN) Asset Utilization Ratio (2017 - 2022)
Imunon's (IMNN) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2022, up 46.89% YoY from 0.01 in Q4 2021, and up 20.43% on a QoQ basis from 0.01 in Q3 2022.
Imunon (IMNN) Asset Utilization Ratio (2017 - 2022) Analysis & Trends
Imunon (IMNN) has 6 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2022.
- Quarterly Asset Utilization Ratio rose 46.89% year-over-year to 0.01 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was 0.01 (up 46.89% YoY) and the FY2022 annual result came in at 0.01, down 5.46% from the prior year.
- Asset Utilization Ratio climbed to 0.01 in Q4 2022, from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q4 2020 to a low of 0.01 in Q3 2021.
- A 5-year average of 0.01 and a median of 0.01 in 2018 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio slumped 51.27% — and 2022, when it soared 46.89%.
- Tracing IMNN's Asset Utilization Ratio over 5 years: stood at 0.01 in 2018, then increased by 11.32% to 0.01 in 2019, then grew by 5.4% to 0.01 in 2020, then plunged by 51.27% to 0.01 in 2021, then soared by 46.89% to 0.01 in 2022.
- The last three Asset Utilization Ratio figures came in at 0.01 (Q4 2022), 0.01 (Q3 2022), and 0.01 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.13 |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.01 |
| Sep 30, 2020 | 0.01 |
| Jun 30, 2020 | 0.01 |
| Mar 31, 2020 | 0.01 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | 0.01 |
| Jun 30, 2019 | 0.01 |
| Mar 31, 2019 | 0.01 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.01 |
| Mar 31, 2018 | 0.01 |